Trial

NCT04609943

Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Bayer
Collaborators
Condition
Acute Respiratory Distress Syndrome
Intervention
BAY1211163
Why stopped
Company Decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19